Influencing factors of acceptance degree of advance care planning for cancer patients
10.3760/cma.j.cn115682-20200415-02744
- VernacularTitle:癌症患者预立医疗照护计划接受程度影响因素研究
- Author:
Lina WU
1
;
Guichun JIANG
;
Xiaoping ZHU
;
Xiaochen XU
Author Information
1. 中国医科大学肿瘤医院 辽宁省肿瘤医院介入科，沈阳 110042
- Keywords:
Neoplasms;
Advance care planning;
Acceptance degree
- From:
Chinese Journal of Modern Nursing
2020;26(36):5046-5051
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore influencing factors of acceptance degree of advance care planning (ACP) for cancer patients.Methods:Using the convenient sampling method, a total of 180 cancer patients who were diagnosed by histopathology or cytology in Liaoning Cancer Hospital and Institute from May 2019 to December 2019 were selected as the research objects. General data questionnaire, Patient's Advance Care Planning Acceptance Questionnaire (ACPQ) , Eysenck Personality Questionnaire-Revised Short Scale for Chinese (EPQ-RSC) and Social Support Rating Scale (SSRS) were used to investigate them and the influencing factors of ACP acceptance of cancer patients were analyzed.Results:A total of 180 questionnaires were issued in this study, including 173 valid questionnaires. The acceptance score of ACPQ for 173 cancer patients was (69.10±7.05) . The results of multiple linear regression analysis showed that education, residence, children's status, religious belief, length of time to know diagnosis, whether sanguine temperament and social support were the influencing factors for ACP acceptance of cancer patients ( P<0.05) . Conclusions:Cancer patients have an accepting attitude towards ACP and are willing to discuss ACP. The degree of acceptance is affected by many factors such as education level, residence, children's status, religious belief, length of time to know diagnosis, personality traits and social support. It is recommended that the popularization of relevant knowledge should be strengthened before the implementation of ACP, and the targeted population should be selected for trial.
